Skip to main content

Animations

MJFF Publications

6241 - 6250 of 8819 Results
Title
Year
  • Year
  • 2025
  • 2021
  • 2022
  • 2022
  • 2020
  • 2025
  • 2025
  • 2025
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70030
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2020-324391
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2021-328547
    Citation Count: 78
  • Summary Details
    RESTRICTED
    Title: Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2022-329433
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
    Journal Name: Molecular Cancer Therapeutics
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259
    Citation Count: 13
  • Summary Details
    OPEN
    Title: AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.4c15013
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psp4.70000
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inhibitory basal ganglia nuclei differentially innervate pedunculopontine nucleus subpopulations and evoke differential motor and valence behaviors
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.102308.3
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson’s disease
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2025.108817
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Acoustically targeted measurement of transgene expression in the brain
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adj7686
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.